Acetylsalicylic acid Enrolling by Invitation Phase 4 Trials for Sclerosis, Progressive Systemic Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03558854Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients